Cargando…
Classifying Polyomavirus Nephropathy: The “Banff” Initiative
Autores principales: | Nickeleit, Volker, Singh, H. K., Davis, Vicki G., Seshan, Surya V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967946/ https://www.ncbi.nlm.nih.gov/pubmed/35368640 http://dx.doi.org/10.3389/ti.2022.10299 |
Ejemplares similares
-
The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era
por: Nickeleit, Volker, et al.
Publicado: (2020) -
Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023) -
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023) -
The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish “Presumptive” from “Definitive” Polyomavirus Nephropathy: How to Use It—When to Use It—How Does It Compare to PCR Based Assays?
por: Nickeleit, Volker, et al.
Publicado: (2021) -
Polyomavirus Nephropathy: Quantitative Urinary Polyomavirus-Haufen Testing Accurately Predicts the Degree of Intrarenal Viral Disease
por: Singh, Harsharan K., et al.
Publicado: (2015)